Jennifer J. Rhodes

2022

In 2022, Jennifer J. Rhodes earned a total compensation of $773.7K as former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary at Elicio Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$12,200
Option Awards$320,613
Salary$440,840
Total$773,653

Rhodes received $440.8K in salary, accounting for 57% of the total pay in 2022.

Rhodes also received $12.2K in non-equity incentive plan and $320.6K in option awards.

Rankings

In 2022, Jennifer J. Rhodes' compensation ranked 3,537th out of 5,625 executives tracked by ExecPay. In other words, Rhodes earned more than 37.1% of executives.

ClassificationRankingPercentile
All
3,537
out of 5,625
37th
Division
Manufacturing
2,004
out of 3,053
34th
Major group
Chemicals And Allied Products
954
out of 1,380
31st
Industry group
Drugs
891
out of 1,281
30th
Industry
Pharmaceutical Preparations
646
out of 927
30th
Source: SEC filing on September 27, 2024.

Rhodes' colleagues

We found three more compensation records of executives who worked with Jennifer J. Rhodes at Elicio Therapeutics in 2022.

2022

Jay Venkatesan

Elicio Therapeutics

Chief Executive Officer

2022

Robert Connelly

Elicio Therapeutics

Chief Executive Officer

2022

Christopher Haqq

Elicio Therapeutics

Chief Medical Officer

News

You may also like